A Study of IDP-001 in Advanced or Metastatic Solid Tumors
A phase 1/2 trial of IDP-001 in head and neck squamous cell carcinoma, cutaneous squamous cell carcinoma, cervical cancer, non-small-cell lung cancer and oesophageal cancer, run by InduPro, Inc., now recruiting.
Overview
A Study of IDP-001 in Advanced or Metastatic Solid Tumors is a phase 1/2 interventional study registered as NCT07602842 by InduPro, Inc., with 132 participants planned, started 2026-07-08 and due to reach its primary completion in 2028-06. Interventions recorded: IDP-001.
Similar pages
not linked directly; found by shared links- TreatmentHMBD-001
Shares Cutaneous squamous cell carcinoma, Oesophageal cancer, Cervical cancer, Head and neck squamous cell carcinoma and the tag pipeline.
- TrialA Study to Evaluate Lenti-HPV-07 Immunotherapy Against HPV+ Cervical or Oropharyngeal Cancer
Shares Cervical cancer, Head and neck squamous cell carcinoma and the tag pipeline.
- TrialA Study to Investigate ALE.P02 as Monotherapy in Adult Patients With Selected CLDN1+ Solid Tumors
Shares Oesophageal cancer, Head and neck squamous cell carcinoma, Non-small-cell lung cancer and the tag pipeline.
- TrialA Study to Investigate the Safety, Pharmacokinetics, and Clinical Activity of AP203 in Patients with Locally Advanced or Metastatic Solid Tumors, and Expansion to Selected Malignancies
Shares Oesophageal cancer, Head and neck squamous cell carcinoma, Non-small-cell lung cancer and the tag pipeline.
- TrialA Study of MT-4561 in Patients With Various Advanced Solid Tumors
Shares Oesophageal cancer, Head and neck squamous cell carcinoma, Non-small-cell lung cancer and the tag pipeline.
- TrialA Study of DM005 in Patients With Advanced Solid Tumors
Shares Head and neck squamous cell carcinoma, Non-small-cell lung cancer and the tag pipeline.
- TrialIntratumoral N17350 in Advanced Solid Tumors
Shares Head and neck squamous cell carcinoma, Non-small-cell lung cancer and the tag pipeline.
- TrialPhase 1/2 Study to Evaluate TH9619 in the Treatment of Advanced Solid Tumors
Shares Head and neck squamous cell carcinoma, Non-small-cell lung cancer and the tag pipeline.